Get the Stockscreener App
12.29
1.87%
0.24
Lensar Inc stock is traded at $12.29, with a volume of 41,110.
It is up +1.87% in the last 24 hours and down -0.61% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
See More
Previous Close:
$12.05
Open:
$12
24h Volume:
41,110
Relative Volume:
0.74
Market Cap:
$146.32M
Revenue:
$42.16M
Net Income/Loss:
$-14.38M
P/E Ratio:
-6.8659
EPS:
-1.79
Net Cash Flow:
$-9.90M
1W Performance:
+2.55%
1M Performance:
-0.61%
6M Performance:
-12.63%
1Y Performance:
+116.11%
1-Day Range:
$12.00
$12.42
1-Week Range:
$11.72
$12.42
52-Week Range:
$5.28
$17.31
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
12.26 | 143.81M | 42.16M | -14.38M | -9.90M | -1.79 |
|
ABT
Abbott Laboratories
|
123.69 | 216.79B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
101.05 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
357.75 | 141.06B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
91.04 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.01 | 49.01B | 5.69B | 1.41B | 577.90M | 6.9828 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
Can LENSAR Inc. stock withstand economic slowdownNew Guidance & Long-Term Safe Investment Plans - newser.com
How LENSAR Inc. stock reacts to global recession fears2025 Key Lessons & Real-Time Buy Zone Alerts - newser.com
Will LENSAR Inc. continue its uptrendEarnings Summary Report & Real-Time Sentiment Analysis - newser.com
Is it time to cut losses on LENSAR Inc.2025 Geopolitical Influence & Low Risk High Win Rate Picks - newser.com
LENSAR (LNSR) to Release Quarterly Earnings on Thursday - MarketBeat
Why LENSAR Inc. stock remains resilientGap Down & Fast Entry and Exit Trade Plans - newser.com
Reversal indicators forming on LENSAR Inc. stockJuly 2025 Recap & Safe Capital Investment Plans - newser.com
How to build a dashboard for LENSAR Inc. stockEarnings Trend Report & Daily Technical Stock Forecast Reports - newser.com
Exit strategy if you’re trapped in LENSAR Inc.Trade Risk Assessment & Low Volatility Stock Recommendations - newser.com
How buybacks impact LENSAR Inc. stock valueJuly 2025 Macro Moves & Low Risk High Win Rate Picks - Fundação Cultural do Pará
Aug Rallies: How buybacks impact LENSAR Inc. stock valueWeekly Investment Report & Entry Point Confirmation Alerts - Fundação Cultural do Pará
LENSAR (NASDAQ:LNSR) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.22%
13.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):